Michael Jewell
Michael Jewell, Partner and Head of Healthcare, joined Cavendish in January 2006 and has advised on many successful sale mandates across a range of sectors, with a particular focus on business services and healthcare. Michael’s transaction experience includes arranging sales to some of the largest global corporates such as the sale of Polar Speed Thermologistics to UPS and the sale of Finsbury Orthopaedics to Johnson and Johnson, as well to private equity purchasers such as the sale of Angel Springs to LDC.
Michael Jewell, Partner and Head of Healthcare, joined Cavendish in January 2006 and has advised on many successful sale mandates across a range of sectors, with a particular focus on business services and healthcare. Michael’s transaction experience includes arranging sales to some of the largest global corporates such as the sale of Polar Speed Thermologistics to UPS and the sale of Finsbury Orthopaedics to Johnson and Johnson, as well to private equity purchasers such as the sale of Angel Springs to LDC.
Articles: Michael Jewell
A Pharma Funding Overview & Outlook for 2020
Opinion / Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry funding in 2019 and gives his perspective on how 2020 will look. As we approach the end of 2019, it’s a good time to look back at how the funding environment…
Latest Report
